Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology

Glioblastoma multiforme

New Jersey

Morristown : Atlantic Health System

Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer

New York

Manhasset : Biomedical Research Alliance of New York

Glioblastoma (Brain Tumor) and Unmethylated MGMT Gene - Adults

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

New York : Biomedical Research Alliance of New York

Newly Diagnosed Glioblastoma Mutiforme (GBM) - Adults

Belgium

Bruxelles : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

France

Nice : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Paris : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Saint Herblain : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Villejuif : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Germany

Berlin : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bochum : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Bonn : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Chemnitz : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Dresden : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Dülmen : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Düsseldorf : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Erfurt : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Frankfurt Am Main : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Freiburg : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Göttingen : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Kiel : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Leipzig : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Mannheim : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Marburg : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

München : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Tübingen : Research Site:

A Study of Avastin (Bevacizumab) and Irinotecan versus Temozolomide Radiochemistry in Patients With Glioblastoma

Italy

Padova : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Torino : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Netherlands

Den Haag : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

Nijmegen : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme

United Kingdom

Glasgow : Research Site:

A Study of Tarceva (Erlotinib) in Patients With Recurrent Glioblastoma Multiforme